Your browser doesn't support javascript.
loading
Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum.
Nakaya, Aya; Shibayama, Hirohiko; Uoshima, Nobuhiko; Yamamura, Ryosuke; Yoshioka, Satoshi; Imada, Kazunori; Shimura, Yuji; Hotta, Masaaki; Matsui, Toshimitsu; Kosugi, Satoru; Hanamoto, Hitoshi; Uchiyama, Hitoji; Yoshihara, Satoshi; Fuchida, Shin-Ichi; Onda, Yoshiyuki; Tanaka, Yasuhiro; Ohta, Kensuke; Matsuda, Mitsuhiro; Kanda, Junya; Yoko, Adachi; Kiyota, Miki; Kawata, Eri; Takahashi, Ryoichi; Fukushima, Kentaro; Tanaka, Hirokazu; Yagi, Hideo; Takakuwa, Teruhito; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Takaori-Kondo, Akifumi; Kuroda, Junya; Matsumura, Itaru; Hino, Masayuki.
Affiliation
  • Nakaya A; Department of Hematology, National Hospital Organization Osaka National Hospital, Japan.
  • Shibayama H; Kansai Myeloma Forum, Japan.
  • Uoshima N; Department of Hematology, National Hospital Organization Osaka National Hospital, Japan.
  • Yamamura R; Kansai Myeloma Forum, Japan.
  • Yoshioka S; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Japan.
  • Imada K; Kansai Myeloma Forum, Japan.
  • Shimura Y; Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Japan.
  • Hotta M; Kansai Myeloma Forum, Japan.
  • Matsui T; Department of Hematology, Japanese Red Cross Osaka Hospital, Japan.
  • Kosugi S; Kansai Myeloma Forum, Japan.
  • Hanamoto H; Department of Hematology, Japanese Red Cross Osaka Hospital, Japan.
  • Uchiyama H; Kansai Myeloma Forum, Japan.
  • Yoshihara S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
  • Fuchida SI; Kansai Myeloma Forum, Japan.
  • Onda Y; First Department of Internal Medicine, Kansai Medical University, Japan.
  • Tanaka Y; Kansai Myeloma Forum, Japan.
  • Ohta K; Department of Hematology, Nishiwaki Municipal Hospital, Japan.
  • Matsuda M; Kansai Myeloma Forum, Japan.
  • Kanda J; Department of Hematology, Toyonaka Municipal Hospital, Japan.
  • Yoko A; Kansai Myeloma Forum, Japan.
  • Kiyota M; Department of Hematology, Kindai University Nara Hospital, Japan.
  • Kawata E; Kansai Myeloma Forum, Japan.
  • Takahashi R; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Japan.
  • Fukushima K; Kansai Myeloma Forum, Japan.
  • Tanaka H; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Japan.
  • Yagi H; Kansai Myeloma Forum, Japan.
  • Takakuwa T; Department of Hematology, Japan Community Healthcare Organization Kyoto Kuramaguchi Medical Center, Japan.
  • Hosen N; Kansai Myeloma Forum, Japan.
  • Ito T; Department of Hematology, Japanese Red Cross Takatsuki Hospital, Japan.
  • Shimazaki C; Kansai Myeloma Forum, Japan.
  • Takaori-Kondo A; Department of Hematology, Japanese Red Cross Wakayama Medical Center, Japan.
  • Kuroda J; Kansai Myeloma Forum, Japan.
  • Matsumura I; Hematology Ohta Clinic, Shinsaibashi, Japan.
  • Hino M; Kansai Myeloma Forum, Japan.
Leuk Res Rep ; 20: 100395, 2023.
Article in En | MEDLINE | ID: mdl-38076634
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Leuk Res Rep Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Leuk Res Rep Year: 2023 Document type: Article